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Abstract
Background: Leishmaniasis is a disease caused by protozoan parasites of genus Leishmania. The frequent involvement of
Leishmania tropica in human leishmaniasis has been recognized only recently. Similarly as L. major, L. tropica causes
cutaneous leishmaniasis in humans, but can also visceralize and cause systemic illness. The relationship between the host
genotype and disease manifestations is poorly understood because there were no suitable animal models.
Methods: We studied susceptibility to L. tropica, using BALB/c-c-STS/A (CcS/Dem) recombinant congenic (RC) strains, which
differ greatly in susceptibility to L. major. Mice were infected with L. tropica and skin lesions, cytokine and chemokine levels
in serum, and parasite numbers in organs were measured.
Principal Findings: Females of BALB/c and several RC strains developed skin lesions. In some strains parasites visceralized
and were detected in spleen and liver. Importantly, the strain distribution pattern of symptoms caused by L. tropica was
different from that observed after L. major infection. Moreover, sex differently influenced infection with L. tropica and L.
major. L. major-infected males exhibited either higher or similar skin pathology as females, whereas L. tropica-infected
females were more susceptible than males. The majority of L. tropica-infected strains exhibited increased levels of
chemokines CCL2, CCL3 and CCL5. CcS-16 females, which developed the largest lesions, exhibited a unique systemic
chemokine reaction, characterized by additional transient early peaks of CCL3 and CCL5, which were not present in CcS-16
males nor in any other strain.
Conclusion: Comparison of L. tropica and L. major infections indicates that the strain patterns of response are species-
specific, with different sex effects and largely different host susceptibility genes.
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Introduction
Several hundred million people in 88 countries are living in
areas where they can contract leishmaniasis, a disease caused by
intracellular protozoan parasites of the genus Leishmania and
transmitted to vertebrates by phlebotomine sand flies. Leishmania
parasites infect professional phagocytes (neutrophils, monocytes
and macrophages), as well as dendritic cells and fibroblasts [1].
The main vertebrate host target cell is the macrophage, where
parasites multiply, eventually rupture the cell, and spread to
uninfected cells [2]. As macrophages migrate to all mammalian
tissues, Leishmania parasites have a great potential for damaging
bodily functions. In the dermis, they cause the cutaneous form of
the disease (which can be localized or diffuse); in the mucosa, they
result in mucocutaneous leishmaniasis; and the metastatic spread
of infection to the spleen and liver leads to visceral leishmaniasis.
One of the major factors determining the type of pathology is the
species of Leishmania [3]. However, the transmitting vector, as well
as genotype, nutritional status of the host, and environmental and
social factors also have a large impact on the outcome of the
disease [3,4]. That is why even patients, infected by the same
species of Leishmania, develop different symptoms [3] and may
differ in their response to therapy [5]. The basis of this
heterogeneity is not well understood [6], but part of this variation
www.plosntds.org 1 June 2012 | Volume 6 | Issue 6 | e1667is likely genetic. Numerous potentially relevant genes were
reported (reviewed in [7]).
The extent of involvement of Leishmania tropica in human
leishmaniasis has been recognized only recently. The western limit
of L. tropica appears to be the Greek Island of Zakynthos, the
disease has been found in Turkey, Syria, Jordan, Israel, Morocco,
Tunisia, Saudi Arabia, Yemen, Iran, Iraq, Afghanistan, Turkme-
nistan, Pakistan, Kenya, Ethiopia and Namibia, and at its eastern
limits in India (reviewed in [8]). While L. major is a zoonosis with
mainly rodent (Gerbillidae) reservoir hosts, L. tropica can circulate
among humans without the involvement of animal reservoirs, but
zoonotic transmission also occurs [9]. Similarly to L. major,
L. tropica causes cutaneous leishmaniasis in humans. Moreover,
L. tropica was also reported to visceralize and cause an initially not
understood systemic illness in veterans returning from endemic
areas in the Middle East [10], as well as the classical visceral
leishmaniasis (kala-azar) in India [11], and the disseminated
cutaneous leishmaniasis accompanied with visceral leishmaniasis
in Iran [12].
A suitable animal model for study of this parasite would
contribute to functional dissection of the clinical course of
infection. Golden hamsters (Mesocricetus auratus) have been consid-
ered to be the best model host of the L. tropica infection, but this
host is not inbred and hence not suitable for many studies.
However, several strains of L. tropica from Afghanistan, India [13],
and Turkey [14] have been described to cause cutaneous disease
in inbred BALB/c mice, thus providing a better defined host. In
comparison with widely studied immune response to L. major
infection (reviewed in [15]) and its genetic control (reviewed in
[7]), little is known about L. tropica in mouse [13,14,16]. Here we
aimed to study genetics of susceptibility to L. tropica in the mouse.
We analyzed response to L. tropica in CcS/Dem (CcS) recombinant
congenic (RC) strains [17] derived from the background strain
BALB/cHeA (BALB/c) and the donor strain STS. Each CcS
strain contains a different unique random set of about 12.5%
genes from the donor strain STS and 87.5% genes from the
background strain BALB/c. These strains have been already
successfully used for analysis of infection with Leishmania major [18–
22]. The RC system enabled us to analyze organ pathology and
systemic disease after infection with L. tropica and their genetic
control.
Materials and Methods
Mice
Males and females of strains BALB/c, STS and selected RC
strains [17,23] were tested. When used for these experiments, RC
strains were in more than 38 generation of inbreeding and
therefore highly homozygous. During the experiment, male and
female mice were placed into separate rooms and males were
caged individually. The research had complied with all relevant
European Union guidelines for work with animals and was
approved by the Institutional Animal Care Committee of the
Institute of Molecular Genetics AS CR and by Departmental
Expert Committee for the Approval of Projects of Experiments on
Animals of the Academy of Sciences of the Czech Republic.
Experiments with Leishmania tropica. Mice of the strains
BALB/c (12 females, 12 males), STS (12 females, 13 males), CcS-3
(12 females, 10 males), CcS-5 (11 females, 12 males), CcS-11 (14
females, 19 males), CcS-12 (6 females, 6 males), CcS-16 (12
females, 12 males), CcS-18 (8 females, 12 males), and CcS-20 (12
females, 12 males) were infected with L. tropica. Mice were tested in
2 successive experimental groups and were killed 21 and 43 weeks
after infection. The age of the mice at the time of infection was 9 to
26 weeks (mean 16 weeks, median 16 weeks).
Experiments with Leishmania major. Mice of the strains
BALB/c (27 females, 30 males), STS (8 females, 10 males), CcS-3
(10 females, 10 males), CcS-5 (26 females, 32 males), CcS-11 (20
females, 21 males), CcS-12 (18 females, 17 males), CcS-16 (11
females, 13 males), CcS-18 (9 females, 4 males), and CcS-20 (14
females, 18 males) were infected with L. major. Mice were tested in
8 successive experimental groups and were killed 8 weeks after
infection. The age of the mice at the time of infection was 8 to 47
weeks (mean 16 weeks, median 15 weeks).
Parasite
Leishmania tropica from Urfa, Turkey (MHOM/1999/TR/SU23)
was used for infecting mice. Amastigotes were transformed to
promastigotes using SNB-9 [24], 1610
7 stationary phase promas-
tigotes from subculture 2 have been inoculated in 50 ml of sterile
saline s.c. into the tail base, with promastigote secretory gel (PSG)
collected from the midgut of L. tropica-infected Phlebotomus sergenti
females (laboratory colony originating from L. tropica focus in
Urfa). PSG was collected as described [25]. The amount
corresponding to one sand fly female was used per mouse.
Leishmania major LV 561 (MHOM/IL/67/LRC-L137 JERI-
CHO II) was used for mouse infection. Amastigotes were
transformed to promastigotes using SNB-9 [24], 1610
7 promas-
tigotes from 6 days old subculture 2 were inoculated in 50 mlo f
sterile saline s.c. into the tail base.
Disease phenotype
The size of the skin lesions was measured weekly using a Vernier
caliper gauge. The mice infected with L. tropica were killed 21 or 43
weeks after inoculation. Mice infected with L. major were killed 8
weeks after infection. Blood, spleen, liver and inguinal lymph
nodes were collected for further analysis.
Quantification of parasite load in spleens and inguinal
lymph nodes
The current semi-quantitative technique is based on the limiting
dilution assay [26]. We modified the procedure by using only a
single pre-selected cell concentration, and parasite count was
Author Summary
Several hundred million people are exposed to the risk of
leishmaniasis, a disease caused by intracellular protozoan
parasites of several Leishmania species and transmitted by
phlebotomine sand flies. In humans, L. tropica causes
cutaneous form of leishmaniasis with painful and long-
persisting lesions in the site of the insect bite, but the
parasites can also penetrate to internal organs. The
relationship between the host genes and development
of the disease was demonstrated for numerous infectious
diseases. However, the search for susceptibility genes in
the human population could be a difficult task. In such
cases, animal models may help to discover the role of
different genes in interactions between the parasite and
the host. Unfortunately, the literature contains only a few
publications about the use of animals for L. tropica studies.
Here, we report an animal model suitable for genetic,
pathological and drug studies in L. tropica infection. We
show how the host genotype influences different disease
symptoms: skin lesions, parasite dissemination to the
lymph nodes, spleen and liver, and increase of levels of
chemokines CCL2, CCL3 and CCL5 in serum.
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Hialeah, FL). In comparison with the original limiting dilution
technique, this modified culture method is less laborious and
allows rapid estimation of parasite number.
Preparation of cells must be carried out under sterile conditions.
During preparation, all samples, which were not immediately
worked with, were kept on ice. Inguinal lymph nodes and quarters
of spleens were disrupted in a glass homogenizer in complete
RPMI (containing 5% of heat-inactivated fetal calf serum (Sigma-
Aldrich, USA), 25 mM Hepes (Sigma-Aldrich, USA), 0.0005% b-
mercaptoethanol (Serva, Germany), 63.7 mg/ml penicillin (Sigma-
Aldrich, USA), and 100 mg/ml streptomycin (Sigma-Aldrich,
USA). The homogenate was passed through the nylon filter.
The homogenizer was washed 3 times with 3 ml of sterile PBS
after processing each lymph node. The samples were then
centrifuged 8 min at 300 g, 4uC (centrifuge Eppendorf 5810 R,
Eppendorf, Germany). The supernatant was removed and the cells
were resuspended in 0.5 ml of complete Schneider’s medium
supplemented with 20% heat-inactivated fetal calf serum (Sigma-
Aldrich, USA), 2% sterile fresh human urine, 50 mg/ml
gentamicine (Sigma-Aldrich, USA), 63.7 mg/ml penicillin (Sig-
ma-Aldrich, USA), and 100 mg/ml streptomycin (Sigma-Aldrich,
USA). To count cells with a Coulter Counter CBC5 (Coulter
Electronics Inc., Hialeah, FL), USA), 50 ml of the cell suspension
was diluted in 20 ml of PBS. Ekoglobin (Hemax s.r.o., Czech
Republic) was added to the diluent prior to counting to lyse red
blood cells.
0.5 ml of the cell suspension (1610
5 cells per ml for lymph
nodes and 2610
5 cells per ml for spleens) was cultivated in
complete Schneider’s medium in 48-well tissue culture plates
(Costar, Corning Inc., USA) at 27uC (Biological thermostat BT
120 M, Labsystem, Finland) for 3 days. Each sample was prepared
in triplicate. After incubation, 100 ml of a mixed sample from each
well, containing Leishmania parasites released from lymph node or
spleen cells were diluted in 20 ml of PBS and the parasite number
was counted with the Coulter Counter.
Quantification of parasite load in livers
Parasite load was measured in frozen liver samples using PCR-
ELISA according to the previously published protocol [27].
Briefly, total DNA was isolated using a standard proteinase
procedure. For PCR, two primers (digoxigenin-labeled F 59-ATT
TTA CAC CAA CCC CCA GTT-39 and biotin-labeled R 59-
GTG GGG AGG GGG CGT TCT-39 (VBC Genomics
Biosciences Research, Austria) were used for amplification of the
120-bp conservative region of the kinetoplast minicircle of
Leishmania parasite, and 50 ng of extracted DNA was used per
each PCR reaction. For a positive control, 20 ng of L. tropica DNA
per reaction was amplified as a highest concentration of standard.
A 40-cycle PCR reaction was used for detection. Parasite load was
determined by analysis of the PCR product with the modified
ELISA protocol (Pharmingen, USA). Concentration of Leishmania
DNA was determined using the ELISA Reader Tecan and the
curve fitter program KIM-E (Schoeller Pharma, Czech Republic)
with least squares-based linear regression analysis.
Cytokine and IgE levels
Levels of GM-CSF (granulocyte-macrophage colony-stimulat-
ing factor), CCL2 (chemokine ligand 2)/MCP-1 (monocyte
chemotactic protein-1), CCL3/MIP-1a (macrophage inflammato-
ry protein-1a), CCL4/MIP-1b (macrophage inflammatory pro-
tein-1b), CCL5/RANTES (regulated upon activation, normal T-
cell expressed, and secreted) and CCL7/MCP-3 (monocyte
chemotactic protein-3) in serum were determined using Mouse
chemokine 6-plex kit (Bender MedSystems, Austria). The kit
contains two sets of beads of different size internally dyed with
different intensities of fluorescent dye. The set of small beads was
used for GM-CSF, CCL5/RANTES and CCL4/MIP-1b and the
set of large beads for CCL3/MIP-1a, CCL2/MCP-1 and CCL7/
MCP-3. The beads are coated with antibodies specifically reacting
with each of the analytes (chemokines) to be detected in the
multiplex system. A biotin secondary antibody mixture binds to
the analytes captured by the first antibody. Streptavidin-phycoer-
ythrin binds to the biotin conjugate and emits a fluorescent signal.
The test procedure was performed in the 96 well filter plates
(Millipore, USA) according to the protocol of Bender MedSystem.
Beads were analyzed on flow cytometer LSR II (BD Biosciences,
USA). As standards were used lyophilized GM-CSF and
chemokines (CCL2/MCP-1, CCL3/MIP1a, CCL4/MIP1b,
CCL5/RANTES, CCL7/MCP-3) supplied in the kit. Concentra-
tion was evaluated by Flow Cytomix Pro 2.4 software (eBioscience,
Vienna, Austria). The limit of detection of each analyte was
determined to be for GM-CSF 12.2 pg/ml, CCL2/MCP-1 42 pg/
ml, CCL7/MCP-3 1.4 pg/ml, CCL3/MIP-1a 1.8 pg/ml, CCL4/
MIP-1b 14.9 pg/ml, CCL5/RANTES 6.1 pg/ml respectively.
IFNc, IL-4, IL-12 and IgE levels in serum were determined
using the primary and secondary monoclonal antibodies (IFNc:
R4-6A2, XMG1.2; IL-4: 11B11, BVD6-24G2; IL-12p40/p70:
C15.6, C17.8; IgE: R35-72, R35118) and standards from BD
Biosciences, USA (recombinant mIFNc, mIL-4, mIL-12 and
purified mIgE: C38-2). ELISA was performed as recommended by
BD Biosciences. The ELISA measurement of IFNc, IL-4, IL-12,
and IgE levels was performed by the ELISA Reader Tecan and
the curve fitter program KIM-E (Schoeller Pharma, Czech
Republic) using least squares-based linear regression analysis.
The detection limit of ELISA was determined to be 30 pg/ml for
IFNc, 8 ng/ml for IgE, 16 pg/ml for IL-4 and 15 pg/ml for IL-12.
Staining of tissue sections
Inguinal lymph nodes and spleens were fixed in 4% formalde-
hyde and embedded in paraffin. Immunohistochemical staining of
parasites was performed in 5 mm lymph node sections. Slides were
deparaffinized with xylene (2 times for 5 min) and rehydrated with
96% ethanol (3 times for 3 min), 80% ethanol (3 min), 70%
ethanol (3 min) and PBS (phosphate buffer saline, 3 min).
Endogenous peroxidase was quenched with 3% H2O2 in methanol
for 10 min. Sections were washed in PBS (10 min) and parasites
were stained using anti-Leishmania lipophosphoglycan monoclonal
mouse IgM (Code Nr. CLP003A, Cedarlane, Canada) diluted
1:100 in PBS with 1% BSA (bovine serum albumine, Sigma-
Aldrich, USA) and applied for 1 h at 37uC, followed by TRITC-
conjugated goat anti-mouse IgM (Code Nr. 115-025-020, Jackson
Immunoresearch, USA), also diluted 1:100 in PBS with 1% BSA
and applied for 1 h at 37uC. Cell nuclei were stained with DAPI
(49,6-diamidino-2-phenylindole dihydrochloride) 10 ng/ml (Sigma-
Aldrich, USA). For histological analysis, 5 mm spleen and lymph
node sections were stained by the routine hematoxylin and eosin
method (H&E).
Statistical analysis
The differences between CcS/Dem strains in parasite numbers
in lymph nodes were evaluated by the analysis of variance
(ANOVA) and Newman-Keuls multiple comparison using the
program Statistica for Windows 8.0 (StatSoft, Inc., Tulsa,
Oklahoma, U.S.A.). Strain and age were fixed factors and
individual experiments were considered as a random parameter.
The differences in parameters between strains were evaluated
using the Newman-Keuls multiple comparison test at 95%
Genetic Influence on Susceptibility to L. tropica
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lymph nodes was analysed by Mann Whitney U test. Analysis of
sex influence on lesion development after L. major infection was
performed using General Linear Models, Univariate ANOVA,
Statistica 8.0 with experiment as a random and age as a fixed
parameter.
Results
Genetic differences in skin pathology caused by infection
with L. tropica
To study susceptibility to L. tropica we infected both females and
males of the strains BALB/c, STS and RC strains CcS-3, CcS-5,
CcS-11, CcS-12, CcS-16, CcS-18, and CcS-20.
In females, skin pathology started as a nodule at the site of L.
tropica infection appearing between weeks 11 and 20, which
transformed in susceptible strains into a skin lesion (Figure 1).
Females of the strains BALB/c, CcS-11, CcS-16 and CcS-20 were
relatively susceptible to the infection and developed skin lesions
after week 18; the largest lesions were observed in CcS-16
(Figure 2A). Females of the strain CcS-16 exhibited skin lesions
from week 18 until the end of experiment (week 43). In females of
the strains BALB/c, CcS-11 and CcS-20, the lesions partly healed
and tended to transform back to nodules after week 30.
Interestingly, in females of the strain CcS-11, small skin nodules
appeared at week 14, but at 32–42 weeks of infection half of the
females died without obvious pathological findings. Only one
female died at week 13 in the 21-week experiment. Strains CcS-12
and CcS-18 are intermediate in susceptibility to skin pathology.
CcS-12 females developed small skin lesions at the late stages of
infection (after week 37), whereas CcS-18 females developed
nodules or small lesions that healed. Strains STS, CcS-3 and CcS-
5 were resistant to skin lesions development. Females of the strain
CcS-3 had small skin nodules at the late stages of infection and did
not develop skin lesions during the entire course of the experiment.
Females of the strains STS and CcS-5 were resistant to L. tropica,
and only a few of them developed small nodules at the site of
infection.
Males of the strain CcS-16 developed small lesions from week
22, which later healed, whereas BALB/c males exhibited small
lesions from week 30 until the end of the experiment (Figure 2B).
Males of the strain CcS-12 developed small skin lesions at the late
stages of infection (after week 37). Males of CcS-11 developed no
or only small skin nodules, but most of the animals died before
week 18 of infection. Similarly as CcS-11 females, they were
without obvious pathological findings. Males of the strains STS,
CcS-3 and CcS-5 had small skin nodules at the late stages of
infection and did not develop skin lesions within the entire course
of the experiment. Only a few males of the strains CcS-18 and
CcS-20 developed small nodules at the site of infection.
Sex has different effect on skin pathology caused by L.
tropica and L. major
Sex differences observed in susceptibility to L. tropica led us to
analyze sex influence in susceptibility to L. major. As our previous
research with L. major was focused on analysis of females [28], in
this study we have infected with L. major both females and males of
strains BALB/c, STS and RC strains CcS-3, CcS-5, CcS-11, CcS-
12, CcS-16, CcS-18, and CcS-20. Both males and females of all
analyzed strains developed larger skin lesions after infection with
L. major than when infected with L. tropica (Table 1, Figure 2A, B).
The effect of sex was different in experiments with L. major and L.
tropica. After the infection with L. tropica, females of CcS/Dem
strains in most cases exhibited more extensive skin pathology than
males (Figure 2 A, B), whereas after infection with L. major, skin
lesions in males and females of strains BALB/c, STS, CcS-11,
CcS-12, CcS-16 and CcS-20 did not differ, whereas males of
strains CcS-3 (P=0.001), CcS-5 (P=0.001) and probably also
CcS-18 (P=0.043) developed larger skin lesions than females
(Table 1).
Figure 1. Skin lesion caused by Leishmania tropica in female of CcS-16 strain at week 43 after infection.
doi:10.1371/journal.pntd.0001667.g001
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different colors. The columns show median values of lesion size in females (A) and males (B). Figure summarizes data from two independent
experiments.
doi:10.1371/journal.pntd.0001667.g002
Table 1. Sex differences in lesion size (week 8) after L. major infection.
Strain Sex Number of mice Lesion size week 8 in mm
2
P-level of difference between females and males
mean ±SD
BALB/c females 27 116.7 630.4 0.098
BALB/c males 30 144.3 660.5
STS females 8 3.0 67.4 0.252
STS males 10 6.9 68.2
CcS-3 females 10 45.2 613.5 0.001
CcS-3 males 10 73.8 617.2
CcS-5 females 26 14.9 615.3 0.001
CcS-5 males 32 29.7 627.9
CcS-11 females 20 61.7 638.1 0.074
CcS-11 males 21 68.6 644.2
CcS-12 females 18 134.6 627.0 0.296
CcS-12 males 17 146.5 644.4
CcS-16 females 11 138.0 632.7 0.105
CcS-16 males 13 160.8 628.2
CcS-18 females 9 97.5 636.8 0.043
CcS-18 males 4 126.2 638.0
CcS-20 females 14 51.6 631.7 0.665
CcS-20 males 18 57.4 636.0
Analysis of sex influence on lesion development was performed using General Linear Models Univariate ANOVA with experiment as a random and age as a fixed
parameter. We have observed influence of experiment (P range 0.006–0.000019), whereas influence of age was not significant (P.0.17).
doi:10.1371/journal.pntd.0001667.t001
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viable L. tropica parasites
In vitro culture tests showed that all tested mice, including strains
that did not exhibit any skin pathology, contained viable parasites in
their inguinal lymph nodes both 21 and 43 weeks after infection
(Figure 3). Presence of parasites was also documented by staining of
Leishmania in tissue smears with the anti-Leishmania lipophosphogly-
can monoclonal antibody (Figure 4) and by histological analysis of
hematoxylin-eosin stained lymph nodes smears (Figure S1).
None of the strains contained more parasites in the lymph nodes
than the background parental strain BALB/c (Figure 3). At week
21 after infection, females of the strains STS and CcS-5
(P=0.0002), and males of the strain CcS-5 (P=0.0093) contained
significantly lower parasite numbers than the strain BALB/c. At
week 43 after infection, females of the strains STS, CcS-5 and
CcS-11 (P=0.00000001), and STS males (P=0.0004) had
significantly lower parasite load than BALB/c. At week 43,
females of strain CcS-18 had higher parasite count than males
(P=0.0209), whereas males of the strain CcS-5 had higher parasite
load than females (P=0.0143). In both experiments counted
together, females of CcS-18 (P=0.0318) strain had higher parasite
load than males, whereas STS males had higher parasite numbers
than females (P=0.0097) (Figure 3).
L. tropica can invade spleens and livers of several mouse
strains
We did not observe any splenomegaly and hepatomegaly
induced by infection with L. tropica. However, in vitro cultures have
shown that 21 weeks after infection 50% (3 out of 6), 66.7% (2 out
of 3) and 16.7% (1 out of 6) spleens of female mice of the strains
CcS-3, -18 and -20, respectively, contained viable parasites. We
were also able to cultivate parasites from 16.7% (1 out of 6) and
33.3% (2 out of 6) of spleens of males of the strains BALB/c and
CcS-20, respectively. Parasite presence in spleens was confirmed
by histological examination (Figure 5). Parasite numbers in spleens
of other strains were either below the level of detection or absent.
Mice of the strain CcS-12 were not tested in the 21-week
experiment.
Later we measured parasite load in frozen liver tissues using
PCR-ELISA [27]. The presence of parasites after 21 weeks of
infection was detected in females of the strains BALB/c 33.33% (2
out of 6), CcS-3 66.67% (4 out of 6), CcS-11 42.86% (3 out of 7),
CcS-16 71.43% (5 out of 7), CcS-18 66.67% (2 out of 3) and CcS-
20 75% (3 out of 4). Livers of males of the same strains also
contained parasites: BALB/c 83.33% (5 out of 6), CcS-3 100% (3
out of 3), CcS-11 80% (4 out of 5), CcS-16 66.67% (4 out of 6),
CcS-18 33% (2 out of 6) and CcS-20 83.33% (5 out of 6).
Unfortunately, an additional analysis of spleens and lymph
nodes with PCR-ELISA cannot be performed as these organs were
completely used for the cultivation assay.
Systemic reactions after infection with L. tropica
We measured levels of IL-4, IL-12, IFNc, GM-CSF (granulo-
cyte-macrophage colony-stimulating factor), CCL2 (chemokine
ligand 2)/MCP-1 (monocyte chemotactic protein-1), CCL3/MIP-
Figure 3. Number of parasites cultivated from lymph nodes of mouse strains 21 and 43 weeks after infection. Mice were killed at week
21 (A) and week 43 (B) after infection. Asterisks show strains that exhibited parasite load significantly different from BALB/c. Brackets indicate strains
with differences between males and females. Data are presented as mean 6 SD.
doi:10.1371/journal.pntd.0001667.g003
Figure 4. Leishmania tropica parasites inside the macrophage. A
smear of the inguinal lymph node of BALB/c male was stained with the
anti-Leishmania lipophosphoglycan monoclonal antibody (CLP003A,
Cedarlane, Hornby, Canada) and TRITC labeled IgM (115-025-020,
Jackson Immunoresearch, West Grove, PA, United States of America), all
diluted 1:100. Nuclei of the cells were stained with DAPI. Parasites are
shown with arrows.
doi:10.1371/journal.pntd.0001667.g004
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rophage inflammatory protein-1b), CCL5/RANTES (regulated
upon activation, normal T-cell expressed, and secreted), CCL7/
MCP-3 (monocyte chemotactic protein-3) and IgE in serum of
uninfected and infected mice.
No significant difference was found in IL-4, IL-12, IgE, IFNc
and GM-CSF levels in serum of infected mice in comparison with
noninfected controls (data not shown). We have observed an
increase of serum levels of CCL2, CCL3 and CCL5 in infected
strains; the largest increase was observed in strains CcS-11, CcS-
16, CcS-18 and CcS-20. Figure 6 shows chemokine kinetics in
females. Peak of increase of levels of these chemokines usually
followed the start of lesion development. The increase was greater
in females than in males (data not shown). Females of the strain
CcS-16 exhibited a unique pattern of kinetics of CCL3 and CCL5
levels, which differed from all other strains (Figure 6) and also from
CcS-16 males (Figure 7). We observed two peaks of increase of
serum levels of CCL3 and CCL5 in females of CcS-16 (Figure 6);
one before the development of skin lesions, the other after the
decrease of lesion size, and there were almost no changes in CCL2
level. CcS-16 males had slight increase of CCL3, CCL5 (Figure 7),
and CCL2 (data not shown); their kinetics of increase was similar
to those in females and males of other strains.
Discussion
We have analyzed manifestations of the disease and the
immunological parameters, which constitute the pathology of
leishmaniasis in mice (organ pathology, parasite load in organs,
systemic immune response) after infection with L. tropica.
Compared with infection with L. major, infection progressed more
slowly, some manifestations (skin lesions, parasite load in organs)
were less pronounced, some (splenomegaly, hepatomegaly) were
absent in the tested strains, and the systemic immune response also
differed. These observations reveal new areas where the compar-
ative research of infection by the two species can contribute to a
deeper genetic and functional understanding of responses to both
and perhaps eventually lead to a common conceptual framework
for their interpretation. Such more general scheme could not be
readily obtained by analysis of any of them alone. A progress in the
heavily under-investigated biology of responses to L. tropica
infection may also have a translational potential, which may be
significant in view of the recent wider recognition of the etiological
role of this parasite in human disease. The areas highlighted by
our results include the likely species specificity of at least some
susceptibility genes, the dramatically different effects of sex on the
response, and a different regulation of some systemic responses.
Genotype effects are different in L. tropica and L. major
infection
We have observed clearly different patterns in strains’ suscep-
tibility to L. tropica and L. major. Out of the nine strains tested, four
(BALB/c, STS, CcS-5, CcS-16) exhibited similar relative suscep-
tibility, whereas susceptibility of five strains (CcS-3, CcS-11, CcS-
12, CcS-18 and CcS-20) to these two parasites differed. Strains
CcS-3 and CcS-20 are resistant and susceptible, respectively, to
development of skin lesions after infection with L. tropica, but
intermediate to infection with L. major. The strains CcS-12, CcS-
18, and CcS-16 are among the most susceptible to L. major
infection [28], (Table 1), whereas with L. tropica CcS-12 and CcS-
18 are clearly less susceptible than BALB/c and CcS-16 (Figure 2).
The mice of strain CcS-11 are intermediate after infection with L.
major, but after infection with L. tropica they died with small or no
lesions, low parasite load in lymph nodes and with no detectable
parasites in spleens. The cause of mortality of CcS-11 was not
revealed by standard histo-pathological investigation. These
differences indicate presence of species-specific susceptibility genes.
Such genes were indicated also by results of Anderson and
coworkers [16] who found that strains BALB/c and C57BL/6 had
similar numbers of parasites in ear dermis and exhibited similar
ear lesion development after infection with L. tropica. In contrast,
these two strains differ greatly in susceptibility to L. major [29],
(reviewed in [7] and [15]). Poly-specific response genes that
control susceptibility to both L. major and L. tropica probably also
exist, as the strains STS and CcS-5 are resistant and BALB/c and
CcS-16 are susceptible to cutaneous disease induced by both
parasite species (Figure 2, Table 1).
These data complement information about species-specific and
poly-specific control of infection to L. donovani, L. infantum, L.
mexicana and L. major (reviewed in [7]). Poly-specific and species-
specific susceptibility genes are not limited to leishmaniasis, but
Figure 5. Parasites in hematoxylin-eosin stained spleen smears. Arrows show a group of parasites among spleen cells in infected BALB/c
male (A); noninfected control BALB/c male without parasites (B).
doi:10.1371/journal.pntd.0001667.g005
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Plasmodium (reviewed in [30]). The data on susceptibility to L.
tropica and L. major reported here is relevant for investigators of
other species-specific responses.
Females of the strain CcS-16 that contains a set of approxi-
mately 12.5% genes of the donor strain STS and 87.5% genes of
the background strain BALB/c exhibited the largest skin
pathology (Figure 1, Figure 2A), exceeding skin manifestations in
both parental strains BALB/c and STS. The observations of
progeny having a phenotype, which is beyond the range of the
phenotype of its parents, are not rare in traits controlled by
multiple genes. It was observed in different tests of immune
responses of RC strains in vitro [31–35] and in vivo [28,36].
Similarly, analysis of gene expression from livers in chromosome
substitution strains revealed that only 438 out of 4209 expression
QTLs were inside the parental range [37]. These observations are
due to multiple gene-gene interactions of QTLs, which in new
combinations of these genes in RC or chromosomal substitution
strains can lead to the appearance of new phenotypes that exceed
their range in parental strains. Alternatively, with traits controlled
by multiple loci, parental strains often contain susceptible alleles at
some of them and resistant at others, and some progeny may
receive predominantly susceptible alleles from both parents.
However, we cannot exclude the possibility that the unique
phenotype of CcS-16 may be caused by a spontaneous mutation,
which had appeared during the inbreeding, similarly as for
example a loss-of-function mutation in pyruvate kinase protecting
RC strains AcB55 and AcB61 against malaria, which is absent in
both parental strains A/J and C57BL/6 [38].
The strains CcS-3 and CcS-5, which are resistant to L. tropica
share common STS-derived segments on chromosome 5 (a small
part near the position 131.01 Mb); chromosome 6 (segment 32-
44 Mb); chromosome 8 (0–14.72 Mb) and on chromosome 10
(114.44–125.42 Mb)([23] and unpublished data). Interestingly, the
segment on chromosome 10 overlaps with Lmr5, which controls
resistance to L. major [19].
Strongsex-genotypeinteractionafterinfectionwithL.tropica
Three phenomena related to sex influence on Leishmania
infection deserve attention: i) a different sex influence on overall
Figure 6. Relationship between chemokine expression and lesion size development during the course of L. tropica infection. Kinetics
of skin lesion development (median, left y axis) and serum levels of CCL2, CCL3 and CCL5 (median values; right y axis) in females are shown. Figure
summarizes data from two independent experiments (21 and 43 weeks of infection).
doi:10.1371/journal.pntd.0001667.g006
Figure 7. Comparison of kinetics of serum level of CCL3 and CCL5 in females and males of strains CcS-16 and BALB/c. Kinetics of CCL3
levels (median values) in serum of BALB/c (A) and CcS-16 (B) and serum levels of CCL5 (median values) in BALB/c (C) and CcS-16 (D) mice is shown.
Figure summarizes data from two independent experiments (21 and 43 weeks of infection).
doi:10.1371/journal.pntd.0001667.g007
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closely related pathogen species L. tropica and L. major (Figure 2,
Table 1), ii) different sex influence on strains’ susceptibility to
development of skin lesions (Figure 2) and on parasite numbers in
lymph nodes (Figure 3), and iii) sex influence on chemokine levels
in serum (Figure 7).
In contrast to L. major infection in CcS/Dem RC strains where
males exhibited either higher or similar pathology as females, in L.
tropica experiments females were more susceptible to skin
pathology than males. However, lymph nodes of females and
males of most RC strains do not differ in L. tropica parasite load.
The only exceptions are lymph nodes of the strains CcS-5 (and
possibly STS), where males exhibit higher numbers of parasites
than females and strain CcS-18, where females exhibit higher
number of parasites than males (Figure 3). We have also observed
a unique transient early peak of serum level of CCL3 and CCL5 in
CcS-16 females, but not in CcS-16 males nor in any other strain
(see the following section). These data suggest that some genes
controlling susceptibility to L. tropica might be sex dependent or
alternatively that this sex influence depends on genotype.
Different sex influence on susceptibility to L. mexicana and L.
major was observed in DBA/2 mice where females were highly
resistant and males susceptible to lesion development after
infection with L. mexicana. On the contrary, although both female
and male mice developed ulcerating lesions after infection with L.
major, lesions healed in males but not in females [39]. Sex
influenced liver parasite burdens after intravenous inoculation of
L. major in strains BALB/cAnPt, DBA/2N and DBA/2J, males
having higher parasite load than females [40].
Genotype influence on sex differences was described in studies of
L. major infection [22,41]. No sex differences in susceptibility were
observed in BALB/cJ mice, whereas male B10.129(10 M)ScSn
mice were relatively resistant to cutaneous disease, while females
developed non-healing ulcerative lesions followed by parasites’
metastases and death [41]
Comparison of L. major susceptibility in two strains, BALB/
cHeA and CcS-11, has shown that there is no significant sex
influence on skin lesion development, splenomegaly and hepato-
megaly in these strains. Parasite numbers in lymph nodes in males
of both strains were higher than in females; however in spleens
only CcS-11 but not BALB/c males had higher numbers than
females. These observations show that sex affects pathology of
various organs differently and that this influence is modified by the
host genotype [22].
These results indicate that data obtained with L. tropica (different
sex influence on susceptibility to two relatively closely related
pathogen species, sex and genotype interaction, and different sex
influence on pathology in different organs) reflect a more general
phenomenon. Other clear sex biases in incidence of disease,
parasite burden, pathology, mortality, and immunological re-
sponse against various parasites, have been observed in humans
and in rodents (reviewed in [42]).
Systemic reactions and a unique pattern of chemokine
response in CcS-16 females, but not males of CcS-16
No significant difference was found in IL-4, IL-12, IFNc and
GM-CSF levels in serum of infected mice in comparison with
noninfected controls (data not shown). This differs from increase of
serum levels of IL-4, IFNc and IL-12 observed in CcS/Dem
strains after 8 weeks of infection [28]. Loci controlling serum levels
of IL-4, IFNc, IL-12, TNFa and IL-6 after 8 weeks of L. major
infection are described in [19,21,22]. Similarly as after L. tropica
infection, no increase was observed in serum GM-CSF level after
infection with L. major (data not shown).
However, the absence of differences in serum levels of IL-4,
IL-12, IFNc and GM-CSF after infection does not exclude the
possibility that they are involved in the local response to L. tropica.
To test this alternative future experiments are needed, similar to
those performed to establish the role of Fli1 (Friend leukemia
integration 1) in L. major infection model [43].
Infection with L. tropica led to increased serum levels of
chemokines CCL2, CCL3 and CCL5. The highest increase was
observed in the strains CcS-11, CcS-16, CcS-18, and CcS-20
(Figure 6, chemokine kinetics in females). The most prominent was
the increase of CCL3/MIP-1a. Unexpectedly and in contrast with
the other strains tested, the CcS-16 females but not males
exhibited a unique pattern of this systemic reaction, characterized
by an additional early peak of chemokine levels before the onset of
cutaneous disease. It suggests that these early peaks of CCL3 and
CCL5 (Figure 7) might be associated with an increased
susceptibility of CcS-16 females to L. tropica. However, they could
also reflect a stronger, but ineffective response.
CCL3 is produced by a range of cell types, including
monocytes/macrophages, lymphocytes, mast cells, basophils,
epithelial cells, and fibroblasts. Similarly, expression of CCL5
can be induced in activated T cells, macrophages, fibroblasts,
epithelial and endothelial cells, and mesanglial cells [44,45].
Although chemokines evolved to benefit the host, inappropriate
regulation or utilization of these proteins can contribute to many
diseases [45].
Both CCL3 and CCL5 bind to receptors CCR1, CCR5 and to
chemokine decoy receptor D6. CCL5 also binds to CCR3 [45].
Genes ccl3 and ccl5 are situated on mouse chromosome 11; genes
ccr1, ccr5 and ccbp2 (D6) are located on mouse chromosome 9
(Table S1). In CcS-16 ccl5 is on a STS-derived segment, whereas
the strain of origin of ccl3 is not yet known; ccr1, ccr5 and ccbp2 are
on BALB/c-derived segment ([23] and unpublished data).
The role of CC-chemokines CCL2, CCL3 and CCL5 in
leishmaniasis has been tested in a number of studies (reviewed in
[46,47]). CCL2 and CCL3 stimulate anti-leishmania response via
the induction of NO-mediated regulatory mechanisms to control
the intracellular growth and multiplication of L. donovani [48].
CCL2 together with CCL3 also significantly enhanced parasite
killing in L. infantum infected human macrophages [49]. In analysis
of susceptibility to L. major in mouse, CCL5 contributed to host
resistance, but CCL2 alone did not correlate with resistance [50].
In humans, CCL2 expression correlated with self healing
cutaneous lesions, whereas CCL3 was associated with lesions of
chronic progressive diffuse cutaneous leishmaniasis caused by L.
mexicana [51]. These studies indicate that a coordinated interaction
of several chemokines is important for successful immune response
against Leishmania, but also that the role of different chemokines in
defense against various Leishmania ssp. might differ. The observed
strain differences and the double peak of CCL3 and CCL5 in CcS-
16 females provide a novel potential starting point for investigation
of the impact of inter-individual differences in chemokine response
on pathogenesis of leishmaniasis.
L. tropica parasites are present in lymph nodes of all
strains, but in much lower numbers than in mice infected
with L. major
In spite of relatively limited pathological symptoms, we found
viable parasites in inguinal lymph nodes of all tested strains
(Figure 3, 4). In some strains (CcS-3, -18, -20 females, and CcS-20
and BALB/c males) we also observed visceralization of parasites in
the spleen (Figure 5); and in females and males of BALB/c, CcS-3,
CcS-11, CcS-16, CcS-18 and CcS-20 we detected parasites in the
liver. Similarly as in previous L. major experiments, which mapped
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distinctness from susceptibility genes [22], our present L. tropica
studies confirmed that the extent of the pathological changes in
different organs did not directly correlate with parasite load. This
was especially obvious in CcS-3 mice, which were resistant to
development of skin pathology, but nevertheless contained
parasites in lymph nodes, spleen and liver. These data indicate
that parasite spread to the different organs and other manifesta-
tions of the disease are dependent on the genome of the host.
Absence of correlation between parasite load in organs or
parasitemia and intensity of disease has been observed also after
infection with several other pathogens such as Toxoplasma gondii
[52], Trypanosoma brucei brucei [53], Trypanosoma congolense [54], and
Plasmodium berghei [55].
In conclusion, the present observation that many of the RC
strains tested with the two Leishmania species exhibited different
susceptibility to L. major and L. tropica demonstrates existence of
species-specific controlling host genes with different functions.
Therefore, without combining the two components of variation
involved in the outcome of Leishmania infection – genetic variation
of the host and species of the parasite - the understanding of the
mechanisms of disease will remain incomplete. On the basis of the
observed strain differences we will perform linkage analysis of the
responsible genes. This information may provide the first step to
distinguishing the species-specific from the general genes control-
ling pathogenesis of leishmaniasis.
Supporting Information
Figure S1 Parasites in hematoxylin-eosin stained lymph
node smears. All tested mice contained viable parasites in their
inguinal lymph nodes. Infected BALB/c female (A); noninfected
control BALB/c female (B); infected BALB/c male (C); nonin-
fected control BALB/c male (D); infected STS female (E);
noninfected control STS female (F); infected STS male (G);
noninfected control STS male (H). Parasites are shown with
arrows.
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